Erik Deichmann Heegaard
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/03/2024
Profilo
Erik Deichmann Heegaard worked as a Medical Director in Novartis Corp.
He then worked as the Chief Medical Officer-GLP 1 Project in Novo Nordisk A from 2011 to 2014.
Currently, he is working as the Chief Medical Officer in Evaxion Biotech A from 2021 to 2023.
Dr. Deichmann Heegaard completed his undergraduate and doctorate degrees from the University of Copenhagen.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EVAXION BIOTECH A/S
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Precedenti posizioni note di Erik Deichmann Heegaard
| Società | Posizione | Fine |
|---|---|---|
| EVAXION BIOTECH A/S | Chief Tech/Sci/R&D Officer | 01/03/2023 |
| NOVO NORDISK A/S | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formazione di Erik Deichmann Heegaard
| University of Copenhagen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| EVAXION BIOTECH A/S | Health Technology |
| Aziende private | 1 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Erik Deichmann Heegaard
